Presence of fluticasone propionate on human nasal mucosal surface and in human nasal tissue over a period of 24 h after intranasal application

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 6, 2001, Pages 532-535

  Bonsmann, U ^a   Bachert, C ^b   Delank, K W ^a   Rohdewald, P ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Fluticasone propionate; Human nasal tissue; Nasal secretion; Tissue binding

Indexed keywords

FLUTICASONE PROPIONATE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NOSE MUCOSA; NOSE SECRETION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TISSUE DISTRIBUTION;

ADMINISTRATION, INTRANASAL; ADULT; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NASAL MUCOSA; RADIOIMMUNOASSAY; RHINITIS, ALLERGIC, PERENNIAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035011319     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.056006532.x     Document Type: Article

References (7)

1. Very low systemic exposure to intranasal fluticasone propionate
2. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo
3. Binding of glucocorticoids to human nasal tissue in vitro
4. Die bindung inhalativer glukokortikoide an menschliches lungengewebe in vitro
5. Lipophilie und rezeptoraffinität von glucocorticoiden
6. Comparison of clinical efficacy of inhaled glucocorticoids
7. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity